ETF Managers Group’s GSK GSK Stock Holding History

ETF Managers Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$142K	Buy	+3,992	New	+$140K	﹤0.01%	615
2022 Q4	–	Sell	-5,570	Closed	-$164K	–	589
2022 Q3	$164K	Buy	5,570 +2,236	+67%	+$84.7K	0.01%	620
2022 Q2	$182K	Sell	3,334 -1,208	-27%	-$66.7K	0.01%	652
2022 Q1	$248K	Sell	4,542 -2,780	-38%	-$151K	0.01%	588
2021 Q4	$404K	Sell	7,322 -2,384	-25%	-$124K	0.01%	552
2021 Q3	$465K	Buy	9,706 +2,264	+30%	+$114K	0.01%	543
2021 Q2	$372K	Sell	7,442 -1,013	-12%	-$48.7K	0.01%	570
2021 Q1	$384K	Buy	8,455 +406	+5%	+$18.4K	0.01%	543
2020 Q4	$373K	Buy	8,049 +887	+12%	+$40.7K	0.01%	478
2020 Q3	$335K	Buy	7,162 +4,594	+179%	+$230K	0.01%	415
2020 Q2	$131K	Buy	+2,568	New	+$132K	﹤0.01%	575

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ETF Managers Group's GSK Position: Q1 2023 in Review

ETF Managers Group opened a new position in GSK (GSK) in Q1 2023: 3,992 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #615 among its holdings. This is a return to the name: ETF Managers Group previously reported a position in GSK as recently as Q3 2022.

ETF Managers Group first reported a position in GSK in Q2 2020 and has held it in 11 quarters since. The position peaked at $465K in Q3 2021. 808 funds tracked by Wall St. Rank hold GSK as of Q1 2023.

ETF Managers Group held 3,992 shares of GSK worth $142K as of Q1 2023.
GSK was a new ETF Managers Group position in Q1 2023.
GSK made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #615 holding.
ETF Managers Group first reported a position in GSK in Q2 2020 and has held it in 11 quarters since.
ETF Managers Group's GSK position peaked at $465K in Q3 2021.
808 funds tracked by Wall St. Rank held GSK as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.